BiomX (PHGE) Proxy filing summary

Executive summary

• Special Meeting called to approve securities issuance for a 60% acquisition of Dr. Frucht Systems Ltd. (DFSL), a reverse stock split, auditor ratification, and potential adjournment.

• DFSL specializes in LADAR-based security and defense systems, with recent revenue growth but ongoing net losses and a going concern warning.

• Acquisition consideration includes shares, warrants, a convertible note, and a revenue-based bonus, with significant dilution potential for existing shareholders.

• Pro forma financials reflect the impact of the DFSL and ZorroNet acquisitions, showing increased goodwill and intangible assets.

Voting matters and shareholder proposals

• Four proposals: (1) issuance of securities to Mandragola Ltd. for DFSL acquisition, (2) reverse stock split at a ratio between 1-for-5 and 1-for-250, (3) ratification of Barzily & Co. as auditor, (4) adjournment if needed.

• Board recommends voting FOR all proposals; Mandragola cannot vote its new shares on the issuance proposal.

• Approval thresholds vary by proposal, with most requiring a majority of votes cast.

Board of directors and corporate governance

• Board retains discretion on timing and ratio of reverse stock split and may abandon it if not in shareholders' best interests.

• No directors or officers have a substantial interest in the issuance proposal outside their roles.